| Factor Information | |
|---|---|
| Data ID | 1435 |
| Factor | mean medium thickness percent |
| Description | N/A |
| Biomarker | NA |
| Classification | E10 (physiological factor - other) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | PAH patients |
| p Value | <0.05 |
| Conclusion | Compared to control group, mean medium thickness percent was higher in RPAH group. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 101 |
| CHD Type | isolated CHD |
| CHD Subtype | CHD with PAH |
| Reference | |
|---|---|
| PMID | 26791551 |
| Year | 2016 |
| Title | Pathologic markers for evaluation of reversibility in pulmonary hypertension related to congenital heart disease |
| Sample | ||
|---|---|---|
| Population | children, adolescent, adult | |
| Source | data | |
| Region | Beijing, China | |
| Method | Pearson χ 2 test | |
| Race | Asian | |
| Disease History | N/A | |
| Treatment History | N/A | |
| Group | reversible pulmonary hypertension-RPAH(Treatment) | control(Control) |
| Number | 24 | 18 |
| Age | 26.3±17.0years | 56.0±8.8 years |
| Gender (Male: Female) | N/A | N/A |
| Marker Level | 8.5±2.0 | 5.7±1.0 |
